Pay in 4 interest-free payments of $5.99 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
Tirzepatide users were also more likely to achieve weight loss milestones, with 42.3% reaching 15% weight loss compared to 18.1% with Semaglutide
E.LewinskiA.et al (2015)
Patients with type 1 diabetes or diabetic ketoacidosis are also excludedtirzepatide is approved for type 2 diabetes and obesity management only
Seek urgent medical care for trouble breathing, swelling of the face or throat, severe abdominal pain that does not settle, or symptoms that feel sudden and serious
Slow and supervised is the point: the patients who keep weight off are the ones whose dose was managed carefully, not rushed
Our trusted partners We proudly collaborate with top brands to ensure every treatment and product meets our highest standards of care.
